CDC study finds Moderna vaccine is best at preventing Covid-19 hospitalization

France Nouvelles Nouvelles

CDC study finds Moderna vaccine is best at preventing Covid-19 hospitalization
France Dernières Nouvelles,France Actualités
  • 📰 politico
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 59%

Moderna’s Covid-19 vaccine is the most effective at protecting against Covid-19 hospitalizations. However, all of the FDA-approved Covid-19 vaccines work well at protecting against hospitalization.

Moderna’s Covid-19 vaccine is the most effective at protecting against Covid-19 hospitalizations, according to a study published Friday by the Centers for Disease Control and Prevention.

The effectiveness of the Pfizer-BioNTech vaccine declined significantly after 120 days, the CDC’s report said, although it still provided strong protection against severe disease.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

politico /  🏆 381. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

COVID-19 Vaccines Won’t Affect Your Sexual Performance, but COVID-19 MightCOVID-19 Vaccines Won’t Affect Your Sexual Performance, but COVID-19 MightJust in case you were wondering.
Lire la suite »

FDA Panel Weighs Covid-19 Booster Shots as Health Officials Debate NeedFDA Panel Weighs Covid-19 Booster Shots as Health Officials Debate NeedThe Biden administration’s push to introduce widespread vaccine boosters faces a test as a Food and Drug Administration advisory panel meets to weigh evidence on the extra shots, a topic that has divided federal health officials.
Lire la suite »

FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine boosterFDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine boosterA panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer Inc /BioNTech SE COVID-19 vaccine for people aged 16 and older.
Lire la suite »

Coronavirus update: FDA booster meeting and Covid-19 vaccine newsCoronavirus update: FDA booster meeting and Covid-19 vaccine newsThe Food and Drug Administration's advisory committee is meeting today to discuss booster doses of coronavirus vaccine. Follow here for the latest news.
Lire la suite »

FDA panel is first key test for Biden COVID-19 booster planFDA panel is first key test for Biden COVID-19 booster planGovernment advisers are debating whether to recommend extra doses of the Pfizer vaccine, a key step toward the Biden administration's plan to dispense COVID-19 booster shots. Scientists have been divided over the need for boosters and who should get them.
Lire la suite »

FDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote FridayFDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote FridayScientists at the FDA said Pfizer’s Covid-19 vaccine seems to last long enough that a booster shot may not add much protection
Lire la suite »



Render Time: 2025-04-17 03:06:16